What's Going On With Becton Dickinson Stock Wednesday?
FDA alerts Becton Dickinson customers to remove recalled Huons sodium chloride ampules from convenience kits. No injuries reported.
Read original at benzingaStocks · News reference
UBS Initiates Coverage On Becton Dickinson with Buy Rating, Announces Price Target of $190
UBS analyst Patrick Wood initiates coverage on Becton Dickinson (NYSE:BDX) with a Buy rating and announces Price Target of $190.
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 28, 2026, 6:23 PM
- Checked
- Jul 28, 2026, 6:23 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
FDA Issues Early Alert For High-Risk Issue With Becton Dickinson Convenience Kits; Becton Dickinson Advises Removal Of Recalled Components From Convenience Kits; Warns Against Use Of Sodium Chloride Ampules In Affected Bd Kits
https://www.fda.gov/medical-devices/medical-device-recalls-and-early-alerts/early-alert-convenience-kit-issue-becton-dickinson
Read original at benzingaMedline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson Products
FDA alerts providers as Medline corrects convenience kits with recalled BD applicators due to sterility and contamination risks.
Read original at benzingaRBC Capital Maintains Sector Perform on Becton Dickinson, Raises Price Target to $190
RBC Capital analyst Kendall Au maintains Becton Dickinson (NYSE:BDX) with a Sector Perform and raises the price target from $180 to $190.
Read original at benzinga